INNATE PHARMA S A (IPHA) — institutional ownership
10 funds reported holding INNATE PHARMA S A in their latest 13F filings, worth $354K in total (CUSIP 45781K204).
Largest holders
- Lion Point Capital, LP — $149K
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $80.1K
- SmartHarvest Portfolios, LLC — $43.7K
- XTX Topco Ltd — $27.8K
- CITADEL ADVISORS LLC — $22.9K
- JANE STREET GROUP, LLC — $19.0K
- RHUMBLINE ADVISERS — $8.68K
- UBS Group AG (UBS) — $2.51K
- Farther Finance Advisors, LLC — $16
- GAMMA Investing LLC — $15
Famous investors holding it
- Ken Griffin portfolio (Citadel Advisors)
Insider buying and selling at INNATE PHARMA S A
Who owns the most IPHA stock?
The largest institutional holders in the latest 13F filings are Lion Point Capital, LP ($149K), MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) ($80.1K), SmartHarvest Portfolios, LLC ($43.7K).
How many funds own IPHA?
10 funds reported holding it, worth $354K in total.